Loading insider details...
Beta
Latest Form 4 (Jan 9, 2026): Grant/Award of 90,000 TGTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 9, 2026 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 90,000 | n/a |
| Jan 30, 2025 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 87,500 | n/a |
| Jan 7, 2025 | TG THERAPEUTICS, INC. (TGTX) | Sale | 11,337 | $343.4K |
| Jan 5, 2024 | TG THERAPEUTICS, INC. (TGTX) | Sale | 47,867 | $809.4K |
| Jun 5, 2023 | TG THERAPEUTICS, INC. (TGTX) | Sale | 73,647 | $1.97M |
| Mar 14, 2023 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 85,000 | n/a |
| Jul 22, 2022 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 75,000 | n/a |
| Jan 7, 2022 | TG THERAPEUTICS, INC. (TGTX) | Sale | 75,312 | $1.45M |
| Jun 22, 2021 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 25,000 | n/a |
| Jan 4, 2021 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 20,000 | n/a |